Form 4: AtriCure Director Shlomo Nachman Acquires Shares Through Restricted Stock Award

Director Shlomo Nachman acquired 7,788 shares of AtriCure, Inc. through a restricted stock award, with vesting occurring one year from the grant date.

Summary

• On May 13, 2024, Shlomo Nachman, a director of AtriCure, Inc., acquired 7,788 shares of common stock through a restricted stock award.
• The acquisition was made under the company's 2023 Stock Incentive Plan.
• These shares will vest on the one-year anniversary of the grant date.
• Following the transaction, Nachman directly owns 13,110 shares of AtriCure common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction (stock award) for a company director. It doesn't inherently indicate positive or negative performance.

Positives

• The acquisition of shares by a director signals confidence in the company's future performance.
• The restricted stock award aligns the director's interests with those of the shareholders.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholders as it demonstrates the director's alignment with the company's success.

Key Dates